Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
NeuroImmunoModulation is Scopus-indexed (Q2, CiteScore 5.5), WoS SCIE, DOAJ. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 1021-7401Verify ISSN ↗1423-0216Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology | 59 / 201 | 70th | Q2 |
| Endocrine and Autonomic Systems | 10 / 23 | 58th | Q2 |
| Endocrinology | 58 / 132 | 56th | Q2 |
| Immunology | 109 / 243 | 55th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present (also 1994–2002), best quartile Q2, CiteScore 5.5.
NeuroImmunoModulation is Q2 in Neurology (rank 59 of 201), Q2 in Endocrine and Autonomic Systems (rank 10 of 23) and Q2 in Endocrinology (rank 58 of 132), by CiteScore 2025. It is ranked in 4 subject areas in all.
NeuroImmunoModulation is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.5, which places it in quartile Q2 at the 70th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.801, quartile Q2, with an H-index of 78.
NeuroImmunoModulation is published by S. Karger AG. Its print ISSN is 1021-7401 and its online ISSN is 1423-0216.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
NeuroImmunoModulation has an h-index of 88 and a 2-year mean of 2.1 citations per paper (OpenAlex). Its Scopus CiteScore is 5.5, quartile Q2. On 2-year citations it ranks #86 of 201 Scopus journals in Neurology.
NeuroImmunoModulation published 27 papers in 2025; its busiest recent year was 2021 with 65. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2023–2026), authors are most often from Germany (20.4%), China (12.4%) and United States (11%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 16 retracted papers are recorded (10.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.